 | • レポートコード：MRC2012B1581 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、口唇ヘルペス治療・予防の世界市場を広く調査・分析し、今後の市場展望をまとめております。口唇ヘルペス治療・予防の種類別市場規模（バラシクロビル、アシクロビル、ファムシクロビル、ドコサノール、その他）、用途別市場規模（外用、経口、注入）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GSK、Livzon、Mylan、Novartis、Daewoong Pharmaceutical、Teva、Med shine、Apotex、Cadila、Luoxin、Haiwang、Bayer (Campho Phenique)、Carmex、Hikma、Blistex、Cipher、Kelun Group、 ・地域別グローバル市場分析 2015年-2020年 ・口唇ヘルペス治療・予防の北米市場（アメリカ、カナダ、メキシコ） ・口唇ヘルペス治療・予防のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・口唇ヘルペス治療・予防のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・口唇ヘルペス治療・予防の南米市場（ブラジル、アルゼンチン） ・口唇ヘルペス治療・予防の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：バラシクロビル、アシクロビル、ファムシクロビル、ドコサノール、その他 ・用途別分析：外用、経口、注入 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Treatment and Prevention of Herpes Labialis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Treatment and Prevention of Herpes Labialis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Treatment and Prevention of Herpes Labialis market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Treatment and Prevention of Herpes Labialis market has been segmented into:
Valacyclovir
Aciclovir
Famciclovir
Docosanol
Other
By Application, Treatment and Prevention of Herpes Labialis has been segmented into:
External Use
Oral
Injection
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Treatment and Prevention of Herpes Labialis market presented in the report. This section sheds light on the sales growth of different regional and country-level Treatment and Prevention of Herpes Labialis markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Treatment and Prevention of Herpes Labialis market.
The report offers in-depth assessment of the growth and other aspects of the Treatment and Prevention of Herpes Labialis market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Treatment and Prevention of Herpes Labialis Market Share Analysis
Treatment and Prevention of Herpes Labialis competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Treatment and Prevention of Herpes Labialis sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Treatment and Prevention of Herpes Labialis sales, revenue and market share for each player covered in this report.
The major players covered in Treatment and Prevention of Herpes Labialis are:
GSK
Livzon
Mylan
Novartis
Daewoong Pharmaceutical
Teva
Med shine
Apotex
Cadila
Luoxin
Haiwang
Bayer (Campho Phenique)
Carmex
Hikma
Blistex
Cipher
Kelun Group
Table of Contents
1 Treatment and Prevention of Herpes Labialis Market Overview
1.1 Product Overview and Scope of Treatment and Prevention of Herpes Labialis
1.2 Classification of Treatment and Prevention of Herpes Labialis by Type
1.2.1 Global Treatment and Prevention of Herpes Labialis Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Type in 2019
1.2.3 Valacyclovir
1.2.4 Aciclovir
1.2.5 Famciclovir
1.2.6 Docosanol
1.2.7 Other
1.3 Global Treatment and Prevention of Herpes Labialis Market by Application
1.3.1 Overview: Global Treatment and Prevention of Herpes Labialis Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 External Use
1.3.3 Oral
1.3.4 Injection
1.4 Global Treatment and Prevention of Herpes Labialis Market by Regions
1.4.1 Global Treatment and Prevention of Herpes Labialis Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Treatment and Prevention of Herpes Labialis (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Treatment and Prevention of Herpes Labialis Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Treatment and Prevention of Herpes Labialis Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Treatment and Prevention of Herpes Labialis Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Treatment and Prevention of Herpes Labialis Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Treatment and Prevention of Herpes Labialis Status and Prospect (2015-2025)
2 Company Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2019)
2.2 Livzon
2.2.1 Livzon Details
2.2.2 Livzon Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Livzon SWOT Analysis
2.2.4 Livzon Product and Services
2.2.5 Livzon Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2019)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Mylan SWOT Analysis
2.3.4 Mylan Product and Services
2.3.5 Mylan Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2019)
2.5 Daewoong Pharmaceutical
2.5.1 Daewoong Pharmaceutical Details
2.5.2 Daewoong Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Daewoong Pharmaceutical SWOT Analysis
2.5.4 Daewoong Pharmaceutical Product and Services
2.5.5 Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva
2.6.1 Teva Details
2.6.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teva SWOT Analysis
2.6.4 Teva Product and Services
2.6.5 Teva Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2019)
2.7 Med shine
2.7.1 Med shine Details
2.7.2 Med shine Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Med shine SWOT Analysis
2.7.4 Med shine Product and Services
2.7.5 Med shine Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2019)
2.8 Apotex
2.8.1 Apotex Details
2.8.2 Apotex Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Apotex SWOT Analysis
2.8.4 Apotex Product and Services
2.8.5 Apotex Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cadila
2.9.1 Cadila Details
2.9.2 Cadila Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Cadila SWOT Analysis
2.9.4 Cadila Product and Services
2.9.5 Cadila Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2019)
2.10 Luoxin
2.10.1 Luoxin Details
2.10.2 Luoxin Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Luoxin SWOT Analysis
2.10.4 Luoxin Product and Services
2.10.5 Luoxin Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2019)
2.11 Haiwang
2.11.1 Haiwang Details
2.11.2 Haiwang Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Haiwang SWOT Analysis
2.11.4 Haiwang Product and Services
2.11.5 Haiwang Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2019)
2.12 Bayer (Campho Phenique)
2.12.1 Bayer (Campho Phenique) Details
2.12.2 Bayer (Campho Phenique) Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Bayer (Campho Phenique) SWOT Analysis
2.12.4 Bayer (Campho Phenique) Product and Services
2.12.5 Bayer (Campho Phenique) Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2019)
2.13 Carmex
2.13.1 Carmex Details
2.13.2 Carmex Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Carmex SWOT Analysis
2.13.4 Carmex Product and Services
2.13.5 Carmex Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2019)
2.14 Hikma
2.14.1 Hikma Details
2.14.2 Hikma Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Hikma SWOT Analysis
2.14.4 Hikma Product and Services
2.14.5 Hikma Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2019)
2.15 Blistex
2.15.1 Blistex Details
2.15.2 Blistex Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Blistex SWOT Analysis
2.15.4 Blistex Product and Services
2.15.5 Blistex Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2019)
2.16 Cipher
2.16.1 Cipher Details
2.16.2 Cipher Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Cipher SWOT Analysis
2.16.4 Cipher Product and Services
2.16.5 Cipher Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2019)
2.17 Kelun Group
2.17.1 Kelun Group Details
2.17.2 Kelun Group Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Kelun Group SWOT Analysis
2.17.4 Kelun Group Product and Services
2.17.5 Kelun Group Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Treatment and Prevention of Herpes Labialis Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Treatment and Prevention of Herpes Labialis Players Market Share
3.2.2 Top 10 Treatment and Prevention of Herpes Labialis Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Treatment and Prevention of Herpes Labialis Revenue and Market Share by Regions
4.2 North America Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
4.3 Europe Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
4.5 South America Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
5 North America Treatment and Prevention of Herpes Labialis Revenue by Countries
5.1 North America Treatment and Prevention of Herpes Labialis Revenue by Countries (2015-2020)
5.2 USA Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
5.3 Canada Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
5.4 Mexico Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
6 Europe Treatment and Prevention of Herpes Labialis Revenue by Countries
6.1 Europe Treatment and Prevention of Herpes Labialis Revenue by Countries (2015-2020)
6.2 Germany Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
6.3 UK Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
6.4 France Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
6.5 Russia Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
6.6 Italy Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Countries
7.1 Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Countries (2015-2020)
7.2 China Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
7.3 Japan Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
7.4 Korea Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
7.5 India Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
8 South America Treatment and Prevention of Herpes Labialis Revenue by Countries
8.1 South America Treatment and Prevention of Herpes Labialis Revenue by Countries (2015-2020)
8.2 Brazil Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
8.3 Argentina Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Treatment and Prevention of Herpes Labialis by Countries
9.1 Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue by Countries (2015-2020)
9.2 Saudi Arabia Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
9.3 UAE Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
9.4 Egypt Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
9.5 South Africa Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Treatment and Prevention of Herpes Labialis Revenue and Market Share by Type (2015-2020)
10.2 Global Treatment and Prevention of Herpes Labialis Market Forecast by Type (2019-2024)
10.3 Valacyclovir Revenue Growth Rate (2015-2025)
10.4 Aciclovir Revenue Growth Rate (2015-2025)
10.5 Famciclovir Revenue Growth Rate (2015-2025)
10.6 Docosanol Revenue Growth Rate (2015-2025)
10.7 Other Revenue Growth Rate (2015-2025)
11 Global Treatment and Prevention of Herpes Labialis Market Segment by Application
11.1 Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Application (2015-2020)
11.2 Treatment and Prevention of Herpes Labialis Market Forecast by Application (2019-2024)
11.3 External Use Revenue Growth (2015-2020)
11.4 Oral Revenue Growth (2015-2020)
11.5 Injection Revenue Growth (2015-2020)
12 Global Treatment and Prevention of Herpes Labialis Market Size Forecast (2021-2025)
12.1 Global Treatment and Prevention of Herpes Labialis Market Size Forecast (2021-2025)
12.2 Global Treatment and Prevention of Herpes Labialis Market Forecast by Regions (2021-2025)
12.3 North America Treatment and Prevention of Herpes Labialis Revenue Market Forecast (2021-2025)
12.4 Europe Treatment and Prevention of Herpes Labialis Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue Market Forecast (2021-2025)
12.6 South America Treatment and Prevention of Herpes Labialis Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Treatment and Prevention of Herpes Labialis Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Treatment and Prevention of Herpes Labialis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Treatment and Prevention of Herpes Labialis Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Treatment and Prevention of Herpes Labialis Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GSK Corporate Information, Location and Competitors
Table 6. GSK Treatment and Prevention of Herpes Labialis Major Business
Table 7. GSK Treatment and Prevention of Herpes Labialis Total Revenue (USD Million) (2017-2018)
Table 8. GSK SWOT Analysis
Table 9. GSK Treatment and Prevention of Herpes Labialis Product and Solutions
Table 10. GSK Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Livzon Corporate Information, Location and Competitors
Table 12. Livzon Treatment and Prevention of Herpes Labialis Major Business
Table 13. Livzon Treatment and Prevention of Herpes Labialis Total Revenue (USD Million) (2018-2019)
Table 14. Livzon SWOT Analysis
Table 15. Livzon Treatment and Prevention of Herpes Labialis Product and Solutions
Table 16. Livzon Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Mylan Corporate Information, Location and Competitors
Table 18. Mylan Treatment and Prevention of Herpes Labialis Major Business
Table 19. Mylan Treatment and Prevention of Herpes Labialis Total Revenue (USD Million) (2017-2018)
Table 20. Mylan SWOT Analysis
Table 21. Mylan Treatment and Prevention of Herpes Labialis Product and Solutions
Table 22. Mylan Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novartis Corporate Information, Location and Competitors
Table 24. Novartis Treatment and Prevention of Herpes Labialis Major Business
Table 25. Novartis Treatment and Prevention of Herpes Labialis Total Revenue (USD Million) (2017-2018)
Table 26. Novartis SWOT Analysis
Table 27. Novartis Treatment and Prevention of Herpes Labialis Product and Solutions
Table 28. Novartis Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Daewoong Pharmaceutical Corporate Information, Location and Competitors
Table 30. Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Major Business
Table 31. Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Total Revenue (USD Million) (2017-2018)
Table 32. Daewoong Pharmaceutical SWOT Analysis
Table 33. Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Product and Solutions
Table 34. Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Teva Corporate Information, Location and Competitors
Table 36. Teva Treatment and Prevention of Herpes Labialis Major Business
Table 37. Teva Treatment and Prevention of Herpes Labialis Total Revenue (USD Million) (2017-2018)
Table 38. Teva SWOT Analysis
Table 39. Teva Treatment and Prevention of Herpes Labialis Product and Solutions
Table 40. Teva Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Med shine Corporate Information, Location and Competitors
Table 42. Med shine Treatment and Prevention of Herpes Labialis Major Business
Table 43. Med shine Treatment and Prevention of Herpes Labialis Total Revenue (USD Million) (2017-2018)
Table 44. Med shine SWOT Analysis
Table 45. Med shine Treatment and Prevention of Herpes Labialis Product and Solutions
Table 46. Med shine Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Apotex Corporate Information, Location and Competitors
Table 48. Apotex Treatment and Prevention of Herpes Labialis Major Business
Table 49. Apotex Treatment and Prevention of Herpes Labialis Total Revenue (USD Million) (2017-2018)
Table 50. Apotex SWOT Analysis
Table 51. Apotex Treatment and Prevention of Herpes Labialis Product and Solutions
Table 52. Apotex Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Cadila Corporate Information, Location and Competitors
Table 54. Cadila Treatment and Prevention of Herpes Labialis Major Business
Table 55. Cadila Treatment and Prevention of Herpes Labialis Total Revenue (USD Million) (2017-2018)
Table 56. Cadila SWOT Analysis
Table 57. Cadila Treatment and Prevention of Herpes Labialis Product and Solutions
Table 58. Cadila Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Luoxin Corporate Information, Location and Competitors
Table 60. Luoxin Treatment and Prevention of Herpes Labialis Major Business
Table 61. Luoxin Treatment and Prevention of Herpes Labialis Total Revenue (USD Million) (2017-2018)
Table 62. Luoxin SWOT Analysis
Table 63. Luoxin Treatment and Prevention of Herpes Labialis Product and Solutions
Table 64. Luoxin Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Haiwang Corporate Information, Location and Competitors
Table 66. Haiwang Treatment and Prevention of Herpes Labialis Major Business
Table 67. Haiwang Treatment and Prevention of Herpes Labialis Total Revenue (USD Million) (2017-2018)
Table 68. Haiwang SWOT Analysis
Table 69. Haiwang Treatment and Prevention of Herpes Labialis Product and Solutions
Table 70. Haiwang Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Bayer (Campho Phenique) Corporate Information, Location and Competitors
Table 72. Bayer (Campho Phenique) Treatment and Prevention of Herpes Labialis Major Business
Table 73. Bayer (Campho Phenique) Treatment and Prevention of Herpes Labialis Total Revenue (USD Million) (2017-2018)
Table 74. Bayer (Campho Phenique) SWOT Analysis
Table 75. Bayer (Campho Phenique) Treatment and Prevention of Herpes Labialis Product and Solutions
Table 76. Bayer (Campho Phenique) Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Carmex Corporate Information, Location and Competitors
Table 78. Carmex Treatment and Prevention of Herpes Labialis Major Business
Table 79. Carmex Treatment and Prevention of Herpes Labialis Total Revenue (USD Million) (2017-2018)
Table 80. Carmex SWOT Analysis
Table 81. Carmex Treatment and Prevention of Herpes Labialis Product and Solutions
Table 82. Carmex Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Hikma Corporate Information, Location and Competitors
Table 84. Hikma Treatment and Prevention of Herpes Labialis Major Business
Table 85. Hikma Treatment and Prevention of Herpes Labialis Total Revenue (USD Million) (2017-2018)
Table 86. Hikma SWOT Analysis
Table 87. Hikma Treatment and Prevention of Herpes Labialis Product and Solutions
Table 88. Hikma Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Blistex Corporate Information, Location and Competitors
Table 90. Blistex Treatment and Prevention of Herpes Labialis Major Business
Table 91. Blistex Treatment and Prevention of Herpes Labialis Total Revenue (USD Million) (2017-2018)
Table 92. Blistex SWOT Analysis
Table 93. Blistex Treatment and Prevention of Herpes Labialis Product and Solutions
Table 94. Blistex Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Cipher Corporate Information, Location and Competitors
Table 96. Cipher Treatment and Prevention of Herpes Labialis Major Business
Table 97. Cipher Treatment and Prevention of Herpes Labialis Total Revenue (USD Million) (2017-2018)
Table 98. Cipher SWOT Analysis
Table 99. Cipher Treatment and Prevention of Herpes Labialis Product and Solutions
Table 100. Cipher Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Kelun Group Corporate Information, Location and Competitors
Table 102. Kelun Group Treatment and Prevention of Herpes Labialis Major Business
Table 103. Kelun Group Treatment and Prevention of Herpes Labialis Total Revenue (USD Million) (2017-2018)
Table 104. Kelun Group SWOT Analysis
Table 105. Kelun Group Treatment and Prevention of Herpes Labialis Product and Solutions
Table 106. Kelun Group Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Global Treatment and Prevention of Herpes Labialis Revenue (Million USD) by Players (2015-2020)
Table 108. Global Treatment and Prevention of Herpes Labialis Revenue Share by Players (2015-2020)
Table 109. Global Treatment and Prevention of Herpes Labialis Revenue (Million USD) by Regions (2015-2020)
Table 110. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Regions (2015-2020)
Table 111. North America Treatment and Prevention of Herpes Labialis Revenue by Countries (2015-2020)
Table 112. North America Treatment and Prevention of Herpes Labialis Revenue Market Share by Countries (2015-2020)
Table 113. Europe Treatment and Prevention of Herpes Labialis Revenue (Million USD) by Countries (2015-2020)
Table 114. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue (Million USD) by Countries (2015-2020)
Table 115. South America Treatment and Prevention of Herpes Labialis Revenue by Countries (2015-2020)
Table 116. South America Treatment and Prevention of Herpes Labialis Revenue Market Share by Countries (2015-2020)
Table 117. Middle East and Africa Treatment and Prevention of Herpes Labialis Revenue (Million USD) by Countries (2015-2020)
Table 118. Middle East and Africa Treatment and Prevention of Herpes Labialis Revenue Market Share by Countries (2015-2020)
Table 119. Global Treatment and Prevention of Herpes Labialis Revenue (Million USD) by Type (2015-2020)
Table 120. Global Treatment and Prevention of Herpes Labialis Revenue Share by Type (2015-2020)
Table 121. Global Treatment and Prevention of Herpes Labialis Revenue Forecast by Type (2021-2025)
Table 122. Global Treatment and Prevention of Herpes Labialis Revenue by Application (2015-2020)
Table 123. Global Treatment and Prevention of Herpes Labialis Revenue Share by Application (2015-2020)
Table 124. Global Treatment and Prevention of Herpes Labialis Revenue Forecast by Application (2021-2025)
Table 125. Global Treatment and Prevention of Herpes Labialis Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Treatment and Prevention of Herpes Labialis Picture
Figure 2. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Type in 2019
Figure 3. Valacyclovir Picture
Figure 4. Aciclovir Picture
Figure 5. Famciclovir Picture
Figure 6. Docosanol Picture
Figure 7. Other Picture
Figure 8. Treatment and Prevention of Herpes Labialis Revenue Market Share by Application in 2019
Figure 9. External Use Picture
Figure 10. Oral Picture
Figure 11. Injection Picture
Figure 12. Global Treatment and Prevention of Herpes Labialis Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Treatment and Prevention of Herpes Labialis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Treatment and Prevention of Herpes Labialis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Treatment and Prevention of Herpes Labialis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Treatment and Prevention of Herpes Labialis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Treatment and Prevention of Herpes Labialis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Treatment and Prevention of Herpes Labialis Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Treatment and Prevention of Herpes Labialis Revenue Market Share in 2019
Figure 21. Global Top 10 Players Treatment and Prevention of Herpes Labialis Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Treatment and Prevention of Herpes Labialis Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Regions (2015-2020)
Figure 25. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Regions in 2018
Figure 26. North America Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 27. Europe Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 29. South America Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 31. North America Treatment and Prevention of Herpes Labialis Revenue Market Share by Countries (2015-2020)
Figure 32. North America Treatment and Prevention of Herpes Labialis Revenue Market Share by Countries in 2019
Figure 33. USA Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 34. Canada Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 36. Europe Treatment and Prevention of Herpes Labialis Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Treatment and Prevention of Herpes Labialis Revenue Market Share by Countries in 2019
Figure 38. Germany Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 39. UK Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 40. France Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 41. Russia Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 42. Italy Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue Market Share by Countries in 2019
Figure 45. China Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 46. Japan Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 47. Korea Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 48. India Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 50. South America Treatment and Prevention of Herpes Labialis Revenue Market Share by Countries (2015-2020)
Figure 51. South America Treatment and Prevention of Herpes Labialis Revenue Market Share by Countries in 2019
Figure 52. Brazil Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Treatment and Prevention of Herpes Labialis Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Treatment and Prevention of Herpes Labialis Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 57. UAE Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2015-2020)
Figure 60. Global Treatment and Prevention of Herpes Labialis Revenue Share by Type (2015-2020)
Figure 61. Global Treatment and Prevention of Herpes Labialis Revenue Share by Type in 2019
Figure 62. Global Treatment and Prevention of Herpes Labialis Market Share Forecast by Type (2021-2025)
Figure 63. Global Valacyclovir Revenue Growth Rate (2015-2020)
Figure 64. Global Aciclovir Revenue Growth Rate (2015-2020)
Figure 65. Global Famciclovir Revenue Growth Rate (2015-2020)
Figure 66. Global Docosanol Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Treatment and Prevention of Herpes Labialis Revenue Share by Application (2015-2020)
Figure 69. Global Treatment and Prevention of Herpes Labialis Revenue Share by Application in 2019
Figure 70. Global Treatment and Prevention of Herpes Labialis Market Share Forecast by Application (2021-2025)
Figure 71. Global External Use Revenue Growth Rate (2015-2020)
Figure 72. Global Oral Revenue Growth Rate (2015-2020)
Figure 73. Global Injection Revenue Growth Rate (2015-2020)
Figure 74. Global Treatment and Prevention of Herpes Labialis Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Treatment and Prevention of Herpes Labialis Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Treatment and Prevention of Herpes Labialis Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Treatment and Prevention of Herpes Labialis Revenue Market Forecast (2021-2025)
Figure 78. Europe Treatment and Prevention of Herpes Labialis Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue Market Forecast (2021-2025)
Figure 80. South America Treatment and Prevention of Herpes Labialis Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Treatment and Prevention of Herpes Labialis Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
口唇ヘルペス治療・予防の世界市場（～2026年） Market Analysis and Insights: Global Treatment and Prevention of Herpes Labialis Market The global Treatment and Prevention of Herpes Labialis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Treatment and Prevention of…- 口唇ヘルペス治療の世界市場（～2026年） Market Analysis and Insights: Global Herpes Labialis Treatment Market The global Herpes Labialis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Herpes Labialis Treatment Scope and Market Size Herpes Labialis…
- 口唇ヘルペス治療薬の世界市場（～2026年） Market Analysis and Insights: Global Herpes Labialis Drugs Market The global Herpes Labialis Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Herpes Labialis Drugs Scope and Market Size Herpes Labialis Drugs marke…
- 帯状疱疹感染症治療の世界市場（～2026年） Herpes Zoster (shingles) is a cutaneous, acute viral infection caused by the varicella-zoster virus. Herpes Zoster is the outbreak of rash on the skin that cause burning and pain. Herpes Zoster is caused by the same virus which cause chickenpox. The virus may live in your nervous system for many yea…
- 性器ヘルペス治療の世界市場（～2026年） Market Analysis and Insights: Global Genital Herpes Treatment Market The global Genital Herpes Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Genital Herpes Treatment Scope and Market Size Genital Herpes Tre…